Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.

NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators

TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.

METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help

NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product

COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors

INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
P
Paneltech International Holdings Inc. Stock Analysis PNLT
Paneltech International Holdings, Inc. engages in the design and manufacture of solid surfaces, wood panel overlays, and saturated media solutions. The company is headquartered in Hoquiam, Washington and currently employs 40 full-time employees. The Company’s products include Fortrex and Overlays. Medium Density Overlays (MDO) which includes PetroFree phenolic glue resin for application directly to hardwood or softwood plywood in a hot press. The company is developed for sign painting and concrete formwork industries; MDO is also used for other applications as a paintable surface. Fortrex has processed aramid and high performance glass fabrics such as DuPont Kevlar and AGY S-2 Glass in support of various MRAP vehicles, HMMWV and Stryker upgrades, and other DoD programs. Fortrex is also expert in processing Owens Corning ShieldStrand Reinforcement S-, R-, and E-glass fabrics, industrial overlay papers and more. Fortrex’s treater lines provide the throughput to rapidly and cost-effectively tackle the largest defense and homeland security projects.
Read More Paneltech International Holdings Inc (PNLT) Chart
Key Statistics of Paneltech International Holdings Inc (PNLT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
235.00P/E Ratio (TTM)
-Market Cap
10.00KAvg. Volume
235.00Dividend Yield
-Financial Metrics & Statements of Paneltech International Holdings Inc (PNLT)
FAQ's for Paneltech International Holdings Inc (PNLT)
- According to Musaffa’s Shariah screening methodology, Paneltech International Holdings Inc (PNLT) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Paneltech International Holdings Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Paneltech International Holdings Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Paneltech International Holdings Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Paneltech International Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Paneltech International Holdings Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.